Comparative assessment of platelet Gp(IIb/IIIa) receptor occupancy ratio with Eptifibatide/Tirofiban in patients presenting with ACS and undergoing PCI

BACKGROUND: The level of platelet inhibition by a Glycoprotein IIb/IIIa (Gp(IIb/IIIa)) antagonist therapy necessary to minimize thrombotic complications in patients undergoing percutaneous coronary intervention (PCI) is a subject of debate. The degree of platelet inhibition obtained 10 min after sta...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Puri, Aniket, Bansal, A., Narain, V.S., Sethi, R., Dwivedi, S.K., Puri, V.K., Saran, R.K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2013
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3861195/
https://ncbi.nlm.nih.gov/pubmed/23647894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2012.08.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller